Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 104,419 | 138,210 | 138,182 | 140,731 | 91,796 |
| Marketable Securities | 241,995 | 221,595 | 197,342 | 209,225 | 256,605 |
| Receivables | 153,773 | 106,003 | 121,070 | 94,280 | 82,054 |
| Inventories | 54,177 | 50,126 | 46,038 | 48,840 | 44,549 |
| Income taxes - deferred | 37,853 | 40,650 | 40,465 | 39,333 | 39,271 |
| Other current assets | 0 | 1,385 | 1,371 | 1,334 | 2,012 |
| TOTAL | $599,935 | $560,883 | $554,528 | $537,506 | $520,694 |
| Non-Current Assets | |||||
| PPE Net | 118,158 | 114,607 | 111,413 | 109,173 | 106,280 |
| Intangibles | 29,824 | 27,574 | 27,574 | 27,574 | 27,574 |
| Other Non-Current Assets | 45,942 | 49,294 | 50,059 | 43,422 | 38,770 |
| TOTAL | $193,924 | $191,475 | $189,046 | $180,169 | $172,624 |
| Total Assets | $793,859 | $752,358 | $743,574 | $717,675 | $693,318 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 22,955 | 17,309 | 18,484 | 16,014 | 18,812 |
| Accrued Expenses | 110,882 | 97,135 | 100,866 | 96,115 | 89,328 |
| TOTAL | $156,861 | $137,876 | $142,763 | $135,358 | $126,416 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 23,024 | 23,432 | 23,413 | 23,229 | 18,276 |
| Other Non-Current Liabilities | 16,926 | 15,998 | 17,176 | 16,651 | 14,577 |
| TOTAL | $34,057 | $37,712 | $44,636 | $49,425 | $58,753 |
| Total Liabilities | $190,918 | $175,588 | $187,399 | $184,783 | $185,169 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,808 | 66,430 | 65,738 | 65,282 | 64,819 |
| Common Shares | 667 | 661 | 659 | 653 | 647 |
| Retained earnings | 316,741 | 294,879 | 277,659 | 265,109 | 251,246 |
| Other shareholders' equity | 1,567 | 1,357 | 3,609 | 2,385 | 2,816 |
| TOTAL | $602,941 | $576,770 | $556,175 | $532,892 | $508,149 |
| Total Liabilities And Equity | $793,859 | $752,358 | $743,574 | $717,675 | $693,318 |